T and NK cells: two sides of tumor immunoevasion

T and NK cells: two sides of tumor immunoevasion

Item
http://www.wikidata.org/entity/Q36753355
Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical ApproachesA novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapyImmunological and Translational Aspects of NK Cell-Based Antitumor ImmunotherapiesPancreatic cancer, treatment options, and GI-4000Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differentiaPancreatic cancer, treatment options, and GI-4000.Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts.Sub-apoptotic dosages of pro-oxidant vitamin cocktails sensitize human melanoma cells to NK cell lysisTumor protective activity of CD4+ but not of CD8+ T cells in DNA-vaccinated mice challenged with bcr-abl-transformed cells.DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy.NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention.
P2860

T and NK cells: two sides of tumor immunoevasion

Item
http://www.wikidata.org/entity/Q36753355
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
T and NK cells: two sides of tumor immunoevasion
@en
type
label
T and NK cells: two sides of tumor immunoevasion
@en
prefLabel
T and NK cells: two sides of tumor immunoevasion
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
T and NK cells: two sides of tumor immunoevasion
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P932